| abstract |
compound kinase inhibitors, pharmaceutical composition that comprises it and its use. the present invention relates to a compound represented by the following structural formula and its pharmaceutically acceptable salts: the compounds represented by this structural formula are kinase inhibitors and, therefore, are disclosed herein for the treatment of cancer. definitions for structural formula variables are provided here. the present invention also relates to a pharmaceutical composition comprising said compound, as well as to the uses of said compound to treat cancer and to manufacture a medicament to treat cancer. |